MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $29,795,000 | +61.8% | 567,759 | +2.6% | 0.01% | +50.0% |
| Q2 2020 | $18,412,000 | +21.5% | 553,445 | -0.7% | 0.01% | 0.0% |
| Q1 2020 | $15,158,000 | +32.7% | 557,278 | -3.8% | 0.01% | +60.0% |
| Q4 2019 | $11,424,000 | +68.8% | 579,038 | +10.9% | 0.01% | +66.7% |
| Q3 2019 | $6,767,000 | +1.1% | 522,142 | -2.9% | 0.00% | 0.0% |
| Q2 2019 | $6,696,000 | -16.8% | 537,857 | -2.9% | 0.00% | -25.0% |
| Q1 2019 | $8,049,000 | +33.3% | 553,947 | +1.3% | 0.00% | +33.3% |
| Q4 2018 | $6,037,000 | -55.9% | 546,759 | +5.1% | 0.00% | -40.0% |
| Q3 2018 | $13,681,000 | +35.7% | 520,153 | +5.5% | 0.01% | +25.0% |
| Q2 2018 | $10,081,000 | -18.9% | 492,949 | -28.0% | 0.00% | -33.3% |
| Q1 2018 | $12,428,000 | +16.1% | 684,810 | -10.7% | 0.01% | +20.0% |
| Q4 2017 | $10,701,000 | -21.4% | 766,960 | +4.2% | 0.01% | -16.7% |
| Q3 2017 | $13,617,000 | +16.5% | 736,068 | +6.4% | 0.01% | 0.0% |
| Q2 2017 | $11,691,000 | +156.3% | 691,778 | +102.5% | 0.01% | +200.0% |
| Q1 2017 | $4,562,000 | -6.3% | 341,666 | +5.6% | 0.00% | -33.3% |
| Q4 2016 | $4,870,000 | +26.0% | 323,492 | -2.1% | 0.00% | +50.0% |
| Q3 2016 | $3,864,000 | +10.2% | 330,542 | +1.9% | 0.00% | 0.0% |
| Q2 2016 | $3,505,000 | +24.2% | 324,502 | +6.3% | 0.00% | 0.0% |
| Q1 2016 | $2,822,000 | -37.2% | 305,309 | +0.8% | 0.00% | -33.3% |
| Q4 2015 | $4,494,000 | -11.8% | 302,916 | -2.5% | 0.00% | 0.0% |
| Q3 2015 | $5,096,000 | -42.7% | 310,539 | -20.4% | 0.00% | -40.0% |
| Q2 2015 | $8,895,000 | +137.2% | 390,022 | +58.1% | 0.01% | +150.0% |
| Q1 2015 | $3,750,000 | +38.9% | 246,714 | +10.0% | 0.00% | 0.0% |
| Q4 2014 | $2,700,000 | +6.6% | 224,228 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $2,532,000 | +0.9% | 223,239 | +7.5% | 0.00% | +100.0% |
| Q2 2014 | $2,509,000 | +8.1% | 207,699 | +4.3% | 0.00% | 0.0% |
| Q1 2014 | $2,321,000 | -32.8% | 199,226 | +1.9% | 0.00% | -50.0% |
| Q4 2013 | $3,456,000 | +36.4% | 195,468 | +11.0% | 0.00% | 0.0% |
| Q3 2013 | $2,534,000 | -1.0% | 176,146 | +3.7% | 0.00% | 0.0% |
| Q2 2013 | $2,559,000 | – | 169,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $45,360,000 | 2.38% |
| Palo Alto Investors LP | 1,757,122 | $22,772,000 | 1.52% |
| Greencape Capital Pty Ltd | 270,280 | $3,503,000 | 1.24% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $12,960,000 | 1.19% |
| Ghost Tree Capital, LLC | 350,000 | $4,536,000 | 1.16% |
| Perceptive Advisors | 2,905,000 | $37,649,000 | 1.01% |
| Eventide Asset Management | 1,236,000 | $16,019,000 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 80,000 | $1,036,000 | 0.48% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 832,627 | $10,791,000 | 0.29% |
| Rock Springs Capital Management LP | 400,000 | $5,184,000 | 0.21% |